Efficacy, Safety and Evolution of Cardiovascular Parameters in Renal Transplant Recipients

NCT01114529 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

828

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: Everolimus
DRUG: Prograf or Neoral

Sponsor

Novartis Pharmaceuticals